Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synexel Research International is a French contract research organization (CRO) specializing in bioanalytical and biomarker services for the pharmaceutical and biotechnology industries. Founded in 1977 and based in Poitiers, the company provides comprehensive support for drug development through highly sensitive method development and validation for new chemical entities and marketed compounds. Its core expertise includes pharmacokinetic and pharmacodynamic analysis using advanced technologies such as LC-MS/MS and various immunoassay platforms. Formerly a division of Parexel International, Synexel was acquired by the Indian CRO Synchron Research Services in 2008, enabling it to offer integrated clinical and bioanalytical solutions globally. The laboratory is GLP-certified and serves a diverse client base across Europe, North America, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synexel Research International.